Cognetivity Neurosciences Ltd
Cognetivity Neurosciences Ltd. operates as a technology company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that allows early diagnosis of dementia; and OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Co… Read more
Cognetivity Neurosciences Ltd (CGNSF) - Total Assets
Latest total assets as of October 2023: $486.61K USD
Based on the latest financial reports, Cognetivity Neurosciences Ltd (CGNSF) holds total assets worth $486.61K USD as of October 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Cognetivity Neurosciences Ltd - Total Assets Trend (2016–2023)
This chart illustrates how Cognetivity Neurosciences Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Cognetivity Neurosciences Ltd - Asset Composition Analysis
Current Asset Composition (January 2023)
Cognetivity Neurosciences Ltd's total assets of $486.61K consist of 93.9% current assets and 6.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 79.3% |
| Accounts Receivable | $370.85K | 13.1% |
| Inventory | $-230.33K | -8.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $109.91K | 3.9% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2016–2023)
This chart illustrates how Cognetivity Neurosciences Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Cognetivity Neurosciences Ltd's current assets represent 93.9% of total assets in 2023, a decrease from 100.0% in 2016.
- Cash Position: Cash and equivalents constituted 79.3% of total assets in 2023, up from 34.3% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 13.1% of total assets.
Cognetivity Neurosciences Ltd Competitors by Total Assets
Key competitors of Cognetivity Neurosciences Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
UCrest Bhd
KLSE:0005
|
Malaysia | RM48.46 Million |
|
Vanfund Urban Investment & Development Co Ltd
SHE:000638
|
China | CN¥265.74 Million |
|
BIT Computer Co. Ltd
KQ:032850
|
Korea | ₩82.38 Billion |
|
ezCaretech Co. LTD
KQ:099750
|
Korea | ₩56.71 Billion |
|
SyntekaBio Inc
KQ:226330
|
Korea | ₩33.49 Billion |
|
Carelabs Co.Ltd
KQ:263700
|
Korea | ₩105.15 Billion |
|
Shanghai Kingstar Winning Software
SHE:300253
|
China | CN¥8.35 Billion |
|
Longmaster Information Tech
SHE:300288
|
China | CN¥1.33 Billion |
Cognetivity Neurosciences Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Cognetivity Neurosciences Ltd generates 0.02x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Cognetivity Neurosciences Ltd is currently not profitable relative to its asset base.
Cognetivity Neurosciences Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.02 | 1.03 | 2.91 |
| Quick Ratio | 0.02 | 1.08 | 3.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-15.38 Million | $ 147.29K | $ 453.46K |
Cognetivity Neurosciences Ltd - Advanced Valuation Insights
This section examines the relationship between Cognetivity Neurosciences Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 189.01 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 41.1% |
| Total Assets | $2.83 Million |
| Market Capitalization | $8.96K USD |
Valuation Analysis
Below Book Valuation: The market values Cognetivity Neurosciences Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Cognetivity Neurosciences Ltd's assets grew by 41.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Cognetivity Neurosciences Ltd (2016–2023)
The table below shows the annual total assets of Cognetivity Neurosciences Ltd from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-01-31 | $2.83 Million | +41.13% |
| 2022-01-31 | $2.00 Million | +9.69% |
| 2021-01-31 | $1.83 Million | +144.34% |
| 2020-01-31 | $748.07K | +4.43% |
| 2019-01-31 | $716.32K | -80.92% |
| 2018-01-31 | $3.75 Million | +5383.04% |
| 2017-01-31 | $68.47K | +12426.62% |
| 2016-01-31 | $546.62 | -- |